PERSPECTIVE THERAPEUTICS, INC. Cash and Restricted Cash
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Cash and Restricted Cash of $59.09 million as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-05-13
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59.09M.
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $60.54M.
- 2021-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $61.87M.
- 2021-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $65.02M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2022-03-31 | $59.09M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $60.54M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $61.87M 10-Q · filed 2021-11-10 |
| 2021-03-31 | $65.02M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $9.77M 10-Q · filed 2022-02-09 |
| 2020-09-30 | $2.12M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $2.57M 10-K · filed 2020-09-25 |
| 2020-03-31 | $2.59M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.36M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $4.76M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $5.51M 10-K · filed 2020-09-25 |
| 2019-03-31 | $4.24M 10-Q · filed 2020-05-13 |
| 2018-12-31 | $3.38M 10-Q · filed 2020-02-12 |
| 2018-09-30 | $2.37M 10-Q · filed 2019-11-13 |
| 2018-06-30 | $2.78M 10-K · filed 2020-09-25 |
| 2018-03-31 | $2.55M 10-Q · filed 2019-05-10 |
| 2017-12-31 | $3.13M 10-Q · filed 2019-02-13 |
| 2017-09-30 | $4.14M 10-Q · filed 2018-11-09 |
| 2017-06-30 | $6.11M 10-K · filed 2020-09-25 |
| 2016-06-30 | $10.32M 10-K · filed 2019-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |